District-Level Integrated Mapping of Onchocerciasis, Lymphatic Filariasis, and Loiasis in Nigeria
Research question
- To define a cost-effective and accurate method to map ivermectin-naïve districts for Onchocerciasis, Lymphatic Filariasis and Loiasis and identify districts eligible for safe treatment with ivermectin MDA.
- To validate a statistical model of Loiasis prevalence and intensity by comparing the model results to data from a prevalence assessment.
Study sites
Andoni and Bonny, Nigeria
Completed
Implementation partner(s)
Sample(s)
Total sample size: 28000 Human
Notes
Sample size for the implementation phase is 6,000. Sample size for the validation phase is roughly 22,000.